Future Liver Programs
Other nonsense mutations causing Liver Stop Codon Disease
DiscoveryPlanned
Key Facts
Indication
Other nonsense mutations causing Liver Stop Codon Disease
Phase
Discovery
Status
Planned
Company
About Alltrna
Alltrna, a Flagship Pioneering company, is unlocking the therapeutic potential of transfer RNA (tRNA) to create a new paradigm in genetic medicine. Its platform aims to treat thousands of diseases with a single, universal tRNA medicine by correcting shared premature termination codon (PTC) mutations. The company has demonstrated preclinical proof-of-concept for its first development candidate, AP003, and is building a robust pipeline for liver and other stop codon diseases. Backed by significant venture capital, Alltrna is led by an experienced team focused on translating its novel platform into transformative therapies.
View full company profile